Home/Filings/4/0001104659-21-100783
4//SEC Filing

Litchman Manuel MD 4

Accession 0001104659-21-100783

CIK 0001680048other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 4:23 PM ET

Size

5.3 KB

Accession

0001104659-21-100783

Insider Transaction Report

Form 4
Period: 2021-07-30
Litchman Manuel MD
DirectorPresident, CEO and Interim CFO
Transactions
  • Purchase

    COMMON STOCK

    2021-07-30$2.91/sh+86,206$250,859960,241 total
Footnotes (2)
  • [F1]Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the purchase transactions on July 30, 2021, was $2.89 to $2.94. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares purchased at each separate price.
  • [F2]Includes restricted stock units, which vest over various time periods.

Issuer

MUSTANG BIO, INC.

CIK 0001680048

Entity typeother

Related Parties

1
  • filerCIK 0001709485

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:23 PM ET
Size
5.3 KB